10-Q · May 14, 2026
MySize, Inc. reported a revenue of $2,394,000 for Q4 2026, an increase from $1,479,000 in Q4 2025. The net loss widened to $1,476,000 from $1,060,000 year-over-year, with gross and operating margins declining…
Earnings analysis · 10-Q
MYSZ earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative MD&A, so revenue, margin, EPS, cash flow, and period-over-period trends cannot be…
Read full summary
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative MD&A, so revenue, margin, EPS, cash flow, and period-over-period trends cannot be assessed from the available text. Controls were deemed effective as of June 30, 2026, and a legal claim was settled for NIS 425,000, approximately $143. The principal updated risk is Nasdaq listing compliance: MVLS was approximately $2.3 million as of August 13, 2026, versus a contemplated $5.0 million threshold, while the related rule remains stayed pending SEC review.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Controls assessed effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026.
-
Legal claim settled
The company resolved the Shimon Shukron litigation for NIS 425,000, approximately $143, payable in three monthly installments; the full amount was accrued as a current liability as of June 30, 2026.
What to watch
-
MVLS below Nasdaq threshold
As of August 13, 2026, the company’s Market Value of Listed Securities was approximately $2.3 million, below the $5.0 million Nasdaq threshold. If the stayed rule becomes effective and the company remains below the threshold for 30 consecutive business days, Nasdaq could issue a Staff Delisting Determination and immediately suspend trading.
-
Ongoing Nasdaq compliance risk
Nasdaq continued-listing standards require a minimum bid price of $1.00 for 30 consecutive trading days and at least $2.5 million in shareholders’ equity. The company states it has previously fallen out of compliance with certain standards, creating ongoing delisting risk.
-
Near-term settlement obligation
The company accrued NIS 425,000, approximately $143, as a current liability for the Shimon Shukron settlement. Although the claim was resolved, the payment creates a near-term cash obligation payable over three monthly installments.
Management's outlook
The supplied 10-Q extract contains no quantitative revenue or EPS outlook. No explicit guidance was provided in the available MD&A text.
Earlier filings 2
10-K · April 15, 2026
MySize positions itself as an integrated “size, commerce, circularity and distribution” platform built from four business units (Naiz Fit, Orgad, Percentil, Ten Peacks) and multiple 2025 acquisitions intended to create…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.